INS and type 2 diabetes mellitus: Recently, the development of new insulin preparations that mimic the normal mealtime bursts of insulin such as aspart insulin and lispro insulin and the availability of new insulin preparations that simulate endogenous basal insulin more precisely such as glargine and detemir may facilitate the ability to achieve long-term control over blood glucose in patients with T2DM [8].